Skillman, NJ, United States of America

Kumaresh Soppimath

This inventor holds 61 USPTO granted patents and 38 published patent applications, plus 4 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Compositions. Top assignees: Nevakar Inc., Nevakar Injectables Inc., Vyluma Inc.. Active years: 2012-2026.

USPTO Granted Patents = 61 

% Patents Active = 85.2

 

 

Average Co-Inventor Count = 3.7

ph-index = 5

Forward Citations = 127(Granted Patents)

Forward Citations (Not Self Cited) = 47(Dec 10, 2025)


Location History:

  • Monmouth, NJ (US) (2012 - 2017)
  • Monmouth Jn, NJ (US) (2017)
  • Monmouth Junction, NJ (US) (2016 - 2019)
  • Plainsboro, NJ (US) (2018 - 2023)
  • Skillman, NJ (US) (2018 - 2024)

Company Filing History:


Years Active: 2012-2026

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Epinephrine Compositions
Norepinephrine Methods
Atropine Formulations
Isoproterenol Compositions
Succinylcholine Syringe
Phenylephrine Containers
Acetaminophen Combinations
Hydralazine Methods
Fixed Dose Combinations
Low-Dose Carbachol
N-Acetylcysteine Methods
Ephedrine Compositions
61 patents (USPTO):Explore Patents

Title: **Kumaresh Soppimath: Innovator in Pharmaceutical Solutions**

Introduction

Kumaresh Soppimath, based in Skillman, NJ, is an accomplished inventor known for his significant contributions to pharmaceutical innovations. With an impressive portfolio of 45 patents, Soppimath's work primarily focuses on enhancing drug delivery systems and formulations, which are critical in medical emergencies.

Latest Patents

Among his latest inventions is a patent for a **Succinylcholine prefilled syringe**. This innovative device allows for emergency administration of drugs using prefilled glass syringes connected through a needleless connector. The design features a drug volume of at least 5 mL, a Luer-lock, and an internal channel diameter of about 1.7 mm, ensuring safe storage of emergency drugs without the risk of plastic leaching or degradation.

Another significant patent involves **Epinephrine compositions and containers**. This inventive subject matter presents ready-to-administer epinephrine compositions that are anti-oxidant free with improved stability. The compositions can be packaged using blow-fill-seal technology or flexible IV bags, maintaining minimal degradation of epinephrine when stored for over a month at temperatures ranging from 2-40° C.

Career Highlights

Kumaresh has made substantial contributions while working with notable companies such as Nevakar Inc. and Nevakar Injectables Inc. His efforts at these organizations have been instrumental in developing innovative pharmaceutical solutions that enhance patient safety and effectiveness in drug administration.

Collaborations

Throughout his career, Soppimath has collaborated with talented professionals such as Tushar Hingorani and Prem Sagar Akasapu. These collaborations have fostered a creative environment for innovation, enabling the team to push boundaries in pharmaceutical research and development.

Conclusion

Kumaresh Soppimath's dedication to innovation in the pharmaceutical industry is evident in his numerous patents and collaborations. His contributions, particularly in creating safer and more efficient drug delivery systems, continue to impact the field positively, ensuring better outcomes in emergency medical situations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…